Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
About this item
Full title
Author / Creator
Diabetes Research in Children Network (DirecNet) and Type 1 Diabetes TrialNet Study Groups , Type 1 Diabetes TrialNet Study Group , Diabetes Research in Children Network (DirecNet) Study Group , Buckingham, Bruce , Beck, Roy W. , Ruedy, Katrina J. , Cheng, Peiyao , Kollman, Craig , Weinzimer, Stuart A. , DiMeglio, Linda A. , Bremer, Andrew A. , Slover, Robert and Tamborlane, William V.
Publisher
Alexandria, VA: American Diabetes Association
Journal title
Language
English
Formats
Publication information
Publisher
Alexandria, VA: American Diabetes Association
Subjects
More information
Scope and Contents
Contents
To assess effectiveness of inpatient hybrid closed-loop control (HCLC) followed by outpatient sensor-augmented pump (SAP) therapy initiated within 7 days of diagnosis of type 1 diabetes on the preservation of β-cell function at 1 year.
Sixty-eight individuals (mean age 13.3 ± 5.7 years; 35% female, 92% Caucasian) were randomized to HCLC followed...
Alternative Titles
Full title
Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
Authors, Artists and Contributors
Author / Creator
Type 1 Diabetes TrialNet Study Group
Diabetes Research in Children Network (DirecNet) Study Group
Buckingham, Bruce
Beck, Roy W.
Ruedy, Katrina J.
Cheng, Peiyao
Kollman, Craig
Weinzimer, Stuart A.
DiMeglio, Linda A.
Bremer, Andrew A.
Slover, Robert
Tamborlane, William V.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3836135
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3836135
Other Identifiers
ISSN
0149-5992
E-ISSN
1935-5548
DOI
10.2337/dc13-1074
